Trial
NCT02885324
Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Indiana University
Collaborators
—
Condition
Glioblastoma Multiforme
Intervention
Cabozantinib
Why stopped
Failure to meet accrual goals.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-10-06